daunorubicin has been researched along with n-vinyl-2-pyrrolidinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akimova, AIa; Li, AD; Rusakov, IG; Shchitkov, KG | 1 |
| Bai, H; Dong, H; Feng, K; Gu, N; Kong, F; Liu, D; Liu, F; Ma, M; Zhang, X; Zhang, Y | 1 |
2 other study(ies) available for daunorubicin and n-vinyl-2-pyrrolidinone
| Article | Year |
|---|---|
[Pharmacokinetics of anthracycline antibiotics deposited by polymers].
Topics: Animals; Carubicin; Cyanoacrylates; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Pharmaceutical Vehicles; Povidone; Rabbits; Rats; Rats, Inbred Strains | 1988 |
Prussian Blue Nanozymes Prevent Anthracycline-Induced Liver Injury by Attenuating Oxidative Stress and Regulating Inflammation.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Catalysis; Chemical and Drug Induced Liver Injury; Chemokines; Daunorubicin; DNA; DNA Damage; Ferrocyanides; Free Radical Scavengers; Inflammation; Mice; Mice, Inbred BALB C; Nanoparticles; Oxidative Stress; Povidone; RAW 264.7 Cells; Reactive Oxygen Species | 2021 |